{
    "Trade/Device Name(s)": [
        "ACL Elite",
        "ACL Elite Pro"
    ],
    "Submitter Information": "Instrumentation Laboratory Company",
    "510(k) Number": "K060162",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000053"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPA"
    ],
    "Summary Letter Date": "February 21, 2006",
    "Summary Letter Received Date": "January 23, 2006",
    "Submission Date": "January 20, 2006",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Factor VIII",
        "Factor IX",
        "Fibrinogen",
        "Prothrombin Time",
        "Activated Partial Thromboplastin Time (APTT)"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ACL Elite",
        "ACL Elite Pro"
    ],
    "Method(s)/Technology(ies)": [
        "Automated coagulation analysis"
    ],
    "Methodologies": [
        "Direct hemostasis measurement",
        "Calculated parameters"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for ACL Elite and ACL Elite Pro automated analyzers for coagulation and fibrinolysis testing in hemostasis laboratories",
    "Indications for Use Summary": "Automated analyzers for in vitro diagnostic clinical use in hemostasis laboratories to perform coagulation and/or fibrinolysis testing for assessment of thrombosis and/or hemostasis",
    "fda_folder": "Hematology"
}